Réglementation et droit · 21/10/20051 min de lecture
Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Patents and Patent Applications Concerning Bacterial Superantigen Vaccines
Traduction automatique locale · Langue originale de la source
Résumé
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent No. 6,399,332 entitled "Bacterial Superantigen Vaccines," issued June 4, 2002; U.S. Patent No. 6,713,284 entitled "Bacterial Superantigen Vaccines," issued March 30, 2004; U.S. Patent Application No. 10/757,687 entitled "Bacterial Superantigen Vaccines," filed January 29, 2004, which is a divisional of U.S. Patent No. 6,713,284; and U.S. Patent Application No. 10/002,784 entitled "Bacterial Superantigen Vaccines," filed November 26, 2001, which is a continuation in part of U.S. Patent No. 6,713,284. Foreign rights are also available (PCT/US98/16766 and PCT/ US01/46540). The United States Government, as represented by the Secretary of the Army, has rights in this invention.